Literature DB >> 8206583

Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction.

K A Jamerson1, S D Smith, J V Amerena, E Grant, S Julius.   

Abstract

We used the insulin-perfused human forearm model to assess the effects of vasoconstriction induced with norepinephrine on the extraction of glucose in the forearm in two groups of healthy young volunteers. The norepinephrine findings were compared with a previously studied group in which vasoconstriction has been caused by reflex activation of the sympathetic nervous system. The aim of the study was to determine the relative importance of hemodynamic and receptor-mediated mechanisms of insulin resistance. Plasma insulin, arterial and venous glucose samples, and forearm blood flow were measured at 10-minute intervals during a 30-minute baseline, a 60-minute intra-arterial insulin infusion, and during 30 minutes of insulin infusion plus vasoconstriction. Group 1 (n = 14) had physiological vasoconstriction induced by inflation of bilateral thigh cuffs to 40 mm Hg to cause pooling of blood in the lower extremities and reflex vasoconstriction in the forearm; group 2 (n = 8) had intra-arterial infusion of norepinephrine to achieve the same degree of vasoconstriction as seen with inflation of thigh cuffs in group 1. Subjects in group 3 (n = 7) had infusion of intra-arterial norepinephrine to achieve a twofold increase in physiological vasoconstriction. With a physiological decrease in forearm blood flow (group 1), there was a 19% decrease in forearm blood flow resulting in a 23% reduction in glucose uptake in the forearm (P < .03). The same degree of reduction in forearm blood flow with a predominantly alpha-adrenergic agonist, norepinephrine (group 2), causes much less insulin resistance (a decrease in utilization of 13%) (P < .04).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206583     DOI: 10.1161/01.hyp.23.6.1006

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

2.  Alpha-receptor blockade improves muscle perfusion and glucose uptake in heart failure.

Authors:  Marc E R Gomes; Alexandra Mulder; Louise Bellersen; Freek W A Verheugt; Paul Smits; Cees J Tack
Journal:  Eur J Heart Fail       Date:  2010-08-05       Impact factor: 15.534

Review 3.  Neurogenic Obesity-Induced Insulin Resistance and Type 2 Diabetes Mellitus in Chronic Spinal Cord Injury.

Authors:  Phillip S Gordon; Gary J Farkas; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

4.  Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Authors:  Nora E Straznicky; Mariee T Grima; Carolina I Sari; Nina Eikelis; Elisabeth A Lambert; Paul J Nestel; Murray D Esler; John B Dixon; Reena Chopra; Alan J Tilbrook; Markus P Schlaich; Gavin W Lambert
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

5.  Association between Resting Heart Rate and Colorectal Cancer: Results from a Case-Controlled Study.

Authors:  Yu-Jin Kwon; Hye Sun Lee; Mi Ra Cho; Si Nae Kim; Justin Y Jeon; Nam Kyu Kim; Ji-Won Lee
Journal:  Int J Environ Res Public Health       Date:  2019-08-12       Impact factor: 3.390

6.  Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.

Authors:  Nora E Straznicky; Elisabeth A Lambert; Gavin W Lambert
Journal:  Diabetes       Date:  2013-01       Impact factor: 9.461

7.  The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion.

Authors:  Juliana S Gil; Luciano F Drager; Grazia M Guerra-Riccio; Cristiano Mostarda; Maria C Irigoyen; Valeria Costa-Hong; Luiz A Bortolotto; Brent M Egan; Heno F Lopes
Journal:  Clinics (Sao Paulo)       Date:  2013-12       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.